Hepatitis C Treatment in Moradabad – Dr. Pabitra Sahu, Gastroenterologist, at Jigyasa Hospital
Who Is Dr. Pabitra Sahu?
Dr. Pabitra Sahu is a specialist in Gastroenterology and Hepatology at Jigyasa Hospital, Moradabad, who provides comprehensive Hepatitis C diagnosis and curative treatment with modern Direct-Acting Antiviral (DAA) therapy and high cure rates. He evaluates patients with Hepatitis C infection, determines appropriate treatment regimens based on genotype and liver damage assessment, and monitors treatment response through follow-up viral load testing.
His approach combines specialist hepatology expertise, evidence-based DAA treatment selection, thorough pre-treatment evaluation including liver fibrosis assessment and medication review, and post-cure confirmation testing to ensure optimal outcomes for patients seeking curative treatment for Hepatitis C.
Understanding Hepatitis C: A Curable Liver Infection
Among the various forms of viral hepatitis, Hepatitis C stands apart for one particularly important reason: it is now curable in the vast majority of cases, thanks to major advances in antiviral medication over the past decade. Yet many patients diagnosed with Hepatitis C remain unaware of this, sometimes carrying years of unnecessary anxiety about a diagnosis that, with proper treatment, has an excellent outcome.
At Jigyasa Hospital, Moradabad, patients receive up-to-date, evidence-based diagnosis and treatment for Hepatitis C under Dr. Pabitra Sahu, supported by a NABL-accredited diagnostic laboratory. Located on Rampur Road, Near Miglani Cinema, Moradabad – 244001, Jigyasa Hospital serves patients from across the region, including Rampur, Sambhal, Amroha, and Bijnor.
What Is Hepatitis C?
Hepatitis C is a viral infection affecting the liver, caused by the Hepatitis C virus (HCV). Unlike Hepatitis A and E, which spread primarily through contaminated food and water, Hepatitis C spreads through contact with infected blood — historically through unscreened blood transfusions, and today more commonly through sharing needles or improperly sterilized medical or dental equipment.
Many people with Hepatitis C have no symptoms for years or even decades after infection, with the disease often discovered incidentally during routine blood tests, blood donation screening, or evaluation for unrelated liver enzyme abnormalities. This "silent" nature is part of why widespread awareness and appropriate screening are so important.
Acute vs. Chronic Hepatitis C
Acute Hepatitis C
This refers to the initial phase of infection, within the first six months. Some individuals clear the virus spontaneously during this period without treatment, though this is less common than with Hepatitis B, occurring in only a minority of cases.
Chronic Hepatitis C
The majority of people who acquire Hepatitis C go on to develop chronic infection, meaning the virus persists long-term in the body. Without treatment, chronic Hepatitis C can lead to progressive liver damage over years to decades, potentially resulting in fibrosis, cirrhosis, and increased risk of liver cancer. However, the critical difference from Hepatitis B is that chronic Hepatitis C can now be cured with appropriate antiviral treatment in the vast majority of patients.
How Is Hepatitis C Diagnosed?
Diagnosis typically involves a two-step testing process:
- • Anti-HCV Antibody Test: This screening test detects antibodies indicating past or current exposure to the virus. A positive result indicates exposure but does not confirm active infection.
- • HCV RNA (Viral Load) Test: This confirms whether the virus is actively present in the blood, distinguishing between a resolved past infection and an active, current infection requiring treatment.
- • Additional testing may include liver function tests, assessment of liver fibrosis through blood markers or elastography, and genotype testing to identify the specific strain of the virus and guide treatment planning.
The Revolution in Hepatitis C Treatment: Direct-Acting Antivirals (DAAs)
The treatment landscape for Hepatitis C has been transformed over the past decade with the introduction of Direct-Acting Antiviral (DAA) medications. Unlike older treatments, which involved lengthy courses of injectable interferon with significant side effects and modest cure rates, modern DAA therapy offers:
- • High Cure Rates: Successfully curing the infection in the vast majority of treated patients.
- • Oral Medication: Taken as pills rather than injections, significantly improving convenience and tolerability.
- • Shorter Treatment Duration: Typically ranging from 8 to 12 weeks, compared to the much longer courses required with older treatment regimens.
- • Fewer Side Effects: Generally well-tolerated compared to older interferon-based treatments, which often caused significant fatigue, flu-like symptoms, and other side effects.
This shift has made Hepatitis C treatment dramatically more accessible and effective than it was even a decade ago, transforming what was once a difficult-to-treat chronic condition into a curable one for most patients.
Specialist Hepatology Expertise
Dr. Pabitra Sahu's training in Gastroenterology and Hepatology ensures accurate diagnosis and appropriate, individualized antiviral treatment selection based on viral genotype and degree of liver damage.
NABL-Accredited Laboratory Testing
Reliable HCV antibody screening, HCV RNA viral load confirmation, liver function tests, and genotype testing to guide treatment planning and monitor treatment response throughout the course.
Comprehensive Pre- and Post-Treatment Monitoring
Thorough pre-treatment evaluation including liver fibrosis assessment and medication review, plus post-cure confirmation testing at 12 weeks and ongoing surveillance for patients with pre-existing cirrhosis.
Modern DAA Therapy with High Cure Rates
Direct-Acting Antiviral medications offering high cure rates (SVR), oral administration, shorter treatment duration (8-12 weeks), and fewer side effects compared to older interferon-based treatments.
Regional Accessibility for Comprehensive Hepatitis C Care
Serving Moradabad, Rampur, Sambhal, Amroha, and Bijnor with comprehensive Hepatitis C testing and curative treatment, bringing specialist hepatology care closer to home.
What Does "Cure" Mean for Hepatitis C?
In the context of Hepatitis C, cure is defined as achieving a "Sustained Virologic Response" (SVR) — meaning the virus remains undetectable in the blood for a defined period (typically 12 weeks) after completing treatment. Patients who achieve SVR are considered cured, with the virus effectively eliminated from the body, and the vast majority of patients treated with modern DAA therapy achieve this outcome.
Treatment Approach for Hepatitis C at Jigyasa Hospital
1. Comprehensive Pre-Treatment Evaluation
Before starting treatment, Dr. Sahu conducts a thorough assessment including confirming active infection through HCV RNA testing, assessing the degree of liver damage present, reviewing other medications to check for potential interactions with antiviral therapy, and assessing for any coexisting liver conditions such as Hepatitis B coinfection or significant alcohol use.
2. Antiviral Treatment Course
Based on the specific viral genotype and degree of liver damage, an appropriate DAA regimen is prescribed, typically taken once daily for the recommended duration. Patients are guided on proper medication adherence, which is important for achieving successful treatment outcomes.
3. Monitoring During Treatment
Periodic follow-up during the treatment course allows monitoring of treatment tolerance and, where relevant, liver function.
4. Confirming Cure
After completing the treatment course, a follow-up HCV RNA test is performed approximately 12 weeks later to confirm sustained virologic response (SVR), confirming successful cure of the infection.
5. Post-Cure Monitoring for Patients with Pre-Existing Cirrhosis
For patients who had already developed significant liver fibrosis or cirrhosis before treatment, ongoing monitoring — including periodic liver imaging for cancer screening — continues even after achieving cure, since the risk of liver cancer, while significantly reduced, does not return entirely to baseline in patients with pre-existing advanced liver disease.
Why Early Diagnosis and Treatment Matter
Since Hepatitis C often causes no symptoms for years, many patients are diagnosed only after some degree of liver damage has already occurred. This underscores the value of appropriate screening, particularly for individuals with recognized risk factors, such as a history of blood transfusion before widespread screening was implemented, or other blood exposure risk factors.
Early diagnosis allows treatment to begin before significant fibrosis or cirrhosis develops, offering the best long-term outcomes.
Who Should Consider Hepatitis C Testing?
- • Individuals who received blood transfusions, particularly before widespread screening protocols were established.
- • Those with a history of exposure to unsterilized needles or medical equipment.
- • Individuals with persistently unexplained elevated liver enzymes.
- • Those with a known history of intravenous drug use.
- • Healthcare workers with potential occupational blood exposure.
- • Anyone with a family member diagnosed with Hepatitis C, given shared risk factor patterns in some cases.
Living with Hepatitis C: What Patients Should Know
- • A Hepatitis C diagnosis today is not the same as it was a decade ago — cure is achievable for the vast majority of patients.
- • Treatment is generally well-tolerated, with most patients able to continue normal daily activities during the treatment course.
- • Patients with advanced liver disease at the time of diagnosis benefit most from early treatment, though even those with cirrhosis can achieve cure and see significant benefit.
- • After confirmed cure, most patients without pre-existing advanced liver disease require no further specific Hepatitis C-related monitoring.
- • Medication adherence during the treatment course is important for achieving successful cure.
Why Choose Jigyasa Hospital for Hepatitis C Care?
Jigyasa Hospital, located on Rampur Road near Miglani Cinema, Moradabad, offers comprehensive Hepatitis C care under specialist hepatology supervision with full diagnostic and treatment support.
- • Specialist Expertise: Dr. Pabitra Sahu's training in Gastroenterology and Hepatology ensures accurate diagnosis and appropriate, individualized antiviral treatment selection.
- • NABL-Accredited Laboratory: Reliable HCV antibody, RNA, and liver function testing.
- • Comprehensive Pre- and Post-Treatment Monitoring: Ensuring both successful cure confirmation and appropriate ongoing care for patients with pre-existing liver damage.
- • Ayushman Bharat PM-JAY Empanelled: Supporting eligible patients with testing and treatment costs.
- • Regional Reach: Serving Moradabad, Rampur, Sambhal, Amroha, and Bijnor.
- • Modern DAA Therapy: High cure rates with well-tolerated oral medications taken for 8-12 weeks.
- • Evidence-Based Approach: Prioritizing patient safety and realistic outcomes.
- • Complete Care Pathway: From diagnosis through cure confirmation and post-treatment follow-up.
Book an Appointment with Dr. Pabitra Sahu
Jigyasa Hospital offers specialist hepatology care for Hepatitis C diagnosis and curative treatment under the guidance of Dr. Pabitra Sahu. Modern DAA therapy with high cure rates, comprehensive monitoring, and well-tolerated oral medications for 8-12 weeks.
Near Miglani Cinema, Rampur Road, Moradabad 244001
Call Now
7900903333Frequently Asked Questions
Is Hepatitis C really curable?
Yes. With modern Direct-Acting Antiviral (DAA) medications, the vast majority of Hepatitis C patients achieve a complete cure, defined as sustained absence of the virus in the blood after treatment completion.
How long does Hepatitis C treatment take?
Most modern treatment regimens last between 8 and 12 weeks, taken as daily oral medication, a significant improvement over older treatments that required much longer courses.
What are the side effects of Hepatitis C treatment?
Modern DAA medications are generally well-tolerated, with most patients experiencing minimal side effects compared to older interferon-based treatments, which were associated with significant fatigue and flu-like symptoms.
If I test positive for Hepatitis C antibodies, does that mean I have an active infection?
Not necessarily. A positive antibody test indicates past exposure, but a separate HCV RNA test is needed to confirm whether the virus is actively present, since some individuals clear the infection naturally without treatment.
Can Hepatitis C come back after being cured?
Once sustained virologic response (SVR) is achieved, the original infection is considered cured and does not typically return. However, reinfection is possible if exposed to the virus again through relevant risk factors, which is different from a relapse of the original infection.
Is Hepatitis C treatment safe for patients who already have cirrhosis?
Yes, patients with cirrhosis can and should be treated, as achieving cure significantly reduces further liver damage and complications, even though some ongoing monitoring for liver cancer risk continues after cure in this group.
How is Hepatitis C different from Hepatitis B in terms of treatment?
Hepatitis C can typically be completely cured with a defined course of antiviral treatment, while chronic Hepatitis B generally requires long-term viral suppression rather than complete cure, reflecting fundamental differences between the two viruses.
Should I get tested for Hepatitis C if I have no symptoms?
Yes, particularly if you have relevant risk factors, since Hepatitis C is often asymptomatic for years. Given how effective and accessible treatment now is, early diagnosis offers a significant advantage in preventing long-term liver damage.
Why Patients Choose Us
- 24/7 Emergency & Trauma Care
- Top Specialist Doctors
- Modern ICU & Operation Theatres
- Transparent & Affordable Pricing
- Ayushman Bharat Empanelled
- Cashless Insurance Support
- Multispeciality Under One Roof
Our Location
Near Miglani Cinema,
Rampur Road,
Moradabad 244001